rs4077515 — CARD9 S12N

CARD9 S12N — Your Antifungal Immune Thermostat

Your immune system relies on a sophisticated surveillance network to detect and destroy fungal invaders. At the center of this network sits CARD9¹¹ CARD9
Caspase Recruitment Domain family member 9, a cytosolic adaptor protein expressed primarily in myeloid cells (macrophages, dendritic cells, neutrophils), an adaptor protein that connects fungal detection at the cell surface to the inflammatory response inside the cell. The rs4077515 variant changes a single amino acid in CARD9 from serine to asparagine at position 12, creating a gain-of-function version²² gain-of-function version
the S12N variant increases CARD9 signaling rather than reducing it, leading to a hyperactive immune state that alters how aggressively your immune system responds to fungi and gut microbes.

The Mechanism

When fungi like Candida or Aspergillus enter your body, immune cells detect them using surface receptors called C-type lectin receptors³³ C-type lectin receptors
a family of pattern-recognition receptors including Dectin-1, Dectin-2, and Mincle that recognize carbohydrate structures on fungal cell walls, particularly Dectin-1, which recognizes beta-glucan on fungal cell walls. This triggers a signaling cascade: Dectin-1 activates the kinase Syk, which recruits CARD9. CARD9 then assembles a CBM complex⁴⁴ CBM complex
CARD9-BCL10-MALT1 signalosome, a multi-protein scaffold that activates the NF-kB transcription factor that activates NF-kB, turning on genes for inflammatory cytokines like TNF-alpha, IL-6, and IL-1beta.

The S12N variant does not affect this classical pathway. Instead, it disrupts the interaction between CARD9 and RelB⁵⁵ disrupts the interaction between CARD9 and RelB
normally, CARD9 sequesters RelB in the cytoplasm; the S12N mutation releases RelB to enter the nucleus, a subunit of the non-canonical NF-kB pathway. In normal CARD9, RelB is held in the cytoplasm. With S12N, RelB translocates to the nucleus and activates IL-5 production in alveolar macrophages⁶⁶ IL-5 production in alveolar macrophages
IL-5 recruits eosinophils and drives type 2 (allergic) immune responses rather than the type 1 responses needed for fungal clearance, recruiting eosinophils and skewing the immune response toward a type 2 (allergic) pattern. This creates a paradox: a hyperactive immune response that is simultaneously less effective at clearing fungi.

The Evidence

The variant was first identified as a disease risk factor in a GWAS of innate immunity genes⁷⁷ GWAS of innate immunity genes
Zhernakova et al. genotyped 354 SNPs across 85 innate immunity genes in 1,851 IBD patients and 1,936 controls in Crohn's disease and ulcerative colitis, with an odds ratio of approximately 1.2 for both conditions. The T allele (encoding asparagine) is common, carried by 43% of Europeans and over 50% of Latino populations, making this a high-frequency, moderate-effect variant rather than a rare mutation.

The most striking clinical association is with allergic bronchopulmonary aspergillosis (ABPA)⁸⁸ allergic bronchopulmonary aspergillosis (ABPA)
a hypersensitivity reaction to Aspergillus fumigatus colonization in the airways, common in asthma and cystic fibrosis patients. A study of 61 ABPA patients, 108 asthma controls, and 156 healthy controls found that heterozygous CT carriers had an OR of 2.69-3.09 for ABPA, while homozygous TT carriers reached OR 4.17. The mutant allele showed allelic expression imbalance⁹⁹ allelic expression imbalance
in heterozygotes, the S12N allele is expressed at higher levels than the wild-type allele, amplifying the gain-of-function effect in heterozygous patients, meaning the variant allele is preferentially expressed even when only one copy is present.

In the gut, the S12N variant increases CARD9 expression and downstream TNF-alpha and IL-6 production¹⁰¹⁰ TNF-alpha and IL-6 production
these pro-inflammatory cytokines, when chronically elevated, drive the tissue damage seen in inflammatory bowel disease, contributing to the chronic inflammation characteristic of Crohn's disease. CARD9 also plays a critical role in controlling fungal colonization of the gut, and the altered signaling may contribute to dysbiotic fungal overgrowth¹¹¹¹ dysbiotic fungal overgrowth
an imbalance in the mycobiome, the fungal component of the gut microbiome in the intestinal tract.

The variant has also been linked to increased susceptibility to candidemia and recurrent vulvovaginal candidiasis, consistent with the paradoxical immune dysfunction where exaggerated type 2 responses impair effective fungal clearance. Separately, CARD9 rs4077515 has been associated with reduced susceptibility to primary immune thrombocytopenia¹²¹² associated with reduced susceptibility to primary immune thrombocytopenia
protective role of the variant allele in ITP in Chinese Han population in a Chinese Han population, suggesting context-dependent immune effects.

Practical Implications

The S12N variant affects two domains: gut health and fungal susceptibility. For gut health, the increased inflammatory signaling contributes to IBD risk, particularly ileal Crohn's disease. For fungal immunity, the type 2 skewing means your immune system may over-react to fungal exposure with allergic responses while under-performing at actual fungal killing.

Carriers should be aware of environmental mold exposure as a modifiable risk factor, particularly for ABPA in those with asthma. Supporting the gut mycobiome balance through targeted probiotics and antifungal dietary strategies can help compensate for the altered immune signaling. Monitoring for signs of fungal overgrowth, especially after antibiotic use that disrupts competing bacterial flora, is particularly relevant for this genotype.

Interactions

CARD9 operates in the same innate immune network as NOD2 (rs2066844), which detects bacterial peptidoglycans. Both converge on NF-kB activation, and carriers of risk variants in both genes may experience compounded gut inflammation. CARD9 S12N also interacts with the autophagy pathway through ATG16L1 (rs2241880), as CARD9 signaling influences autophagic clearance of intracellular fungi. The combination of impaired autophagy (ATG16L1 risk variant) and hyperactive CARD9 signaling (S12N) could amplify intestinal inflammation while reducing microbial clearance efficiency. Similarly, IRGM (rs13361189) variants affecting autophagy may compound the fungal clearance deficit in S12N carriers.